The Valley Desk

ArticleAdvances in therapyPublished

Comparative Effectiveness of Mepolizumab Versus Dupilumab in Medicare Fee-for-Service Beneficiaries with Asthma: A Real-World Cohort Study

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names GSK. Affiliation source

Institution
GSK

Publication record

Type
Article
Venue
Advances in therapy
Published
Subject terms
Asthma; Biologic Therapy; Medicare; Mepolizumab; Dupilumab; Real-world Evidence
PubMed ID
42886433
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal